Close Menu

NEW YORK – Natera is selling its Evercord cord blood and tissue banking business to CBR (Cord Blood Registry), a California Cryobank Life Sciences company, the firms said today.

"This divestiture will allow Natera to focus squarely on its core genetic testing business in reproductive health, oncology, and organ transplantation," Natera CEO Steve Chapman said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.